Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: DNTH) | Delayed: 78.00 -0.53 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.53 | 52 Week High | $ | |||
| Open | $76.03 | 52 Week Low | $ | |||
| Day High | $78.16 | P/E | N/A | |||
| Day Low | $76.02 | EPS | $ | |||
| Volume | 88,055 | |||||
